Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type, and Country | Forecast 2021-2028
Triton’s research report has determined
that the North America sepsis diagnostics market is predicted to experience
growth at a CAGR of 7.99% through the calculated years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries discussed in
this market are:
• United States
• Canada
The well-developed healthcare
infrastructure has resulted in the high adoption of sepsis diagnostic
instruments in laboratories and diagnostic centers across the region. Moreover,
favorable healthcare reimbursement has motivated higher penetration of
automated sepsis diagnostic analyzers in the region’s nations. These factors
largely support the robust growth of the sepsis diagnostics market across North
America.
As per Centers for Disease Control and Prevention (CDC), each year, a
significant amount of the population develops sepsis, leading to higher
mortality rates in the United States. Moreover, around one in three patients
admitted to the hospital dies due to sepsis. This rise in sepsis cases in the
country is due to the increase in the geriatric population, infections that are
incurable by antibiotics, and a high risk of disease among patients undergoing
an organ transplant. Further, the CDC launched an initiative, Get Ahead of
Sepsis, to protect citizens from sepsis’s adverse effects. This initiative focuses
on encouraging professionals to educate patients, prevent infections, and
diagnose sepsis early. Hence, the above-stated factors, along with favorable
initiatives, are expected to augment the growth of the sepsis diagnostics
market in the US.
On the other hand, Canada
spends significantly on its healthcare infrastructure. As per estimates,
healthcare spending represents a significant amount of the country’s gross
domestic product. Sepsis is evaluated as the 12th leading cause of
death in Canada, as per the Canadian Sepsis Foundation. Here, the government
spends a large sum on treating sepsis. Hence, the rise in sepsis, coupled with
high healthcare expenditure, increases the demand for sepsis diagnostics, in
turn, fueling the development of the sepsis diagnostics market across Canada.
Thermo Fisher Scientific Inc is
a leading company serving a wide consumer base globally. Its business segments
include laboratory products, analytical instruments, specialty diagnostics, and
life sciences solutions. Also, the company manufactures and delivers its
products to research institutes and government agencies, hospitals, diagnostic
labs, and pharmaceutical companies. Thermo Fisher was founded in 2006, having
headquarters located in Massachusetts, the United States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA SEPSIS DIAGNOSTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. CONTRACTS
AND PARTNERSHIP
2.6.2. BUSINESS
EXPANSION AND DIVESTITURES
2.6.3. ACQUISITIONS
& MERGERS
2.6.4. NEW
PRODUCT LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN HOSPITAL-ACQUIRED INFECTIONS AMONG PATIENTS
2.7.2. INCREASED
PREVALENCE OF SEPSIS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST ASSOCIATED WITH THE INSTRUMENT
2.8.2. REIMBURSEMENT
ISSUES
2.9. MARKET
OPPORTUNITIES
2.9.1. RISING
GOVERNMENT INITIATIVES FOR RESEARCH ACTIVITIES RELATED TO SEPSIS
3. NORTH
AMERICA SEPSIS DIAGNOSTICS MARKET - BY TECHNOLOGY
3.1. MICROBIOLOGY
3.2. IMMUNOASSAY
3.3. MOLECULAR
DIAGNOSTICS
3.4. OTHER
TECHNOLOGIES
4. NORTH
AMERICA SEPSIS DIAGNOSTICS MARKET - BY DIAGNOSTIC METHOD
4.1. CONVENTIONAL
DIAGNOSTICS
4.2. AUTOMATED
DIAGNOSTICS
5. NORTH
AMERICA SEPSIS DIAGNOSTICS MARKET - BY PRODUCT
5.1. BLOOD
CULTURE MEDIA
5.2. ASSAY
KITS & REAGENTS
5.3. INSTRUMENTS
6. NORTH
AMERICA SEPSIS DIAGNOSTICS MARKET - BY PATHOGEN
6.1. GRAM
- POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS
6.2. FUNGAL
SEPSIS
6.3. OTHER
PATHOGENS
7. NORTH
AMERICA SEPSIS DIAGNOSTICS MARKET - BY TESTING TYPE
7.1. LABORATORY
TESTING
7.2. POINT-OF-CARE
TESTING
8. NORTH
AMERICA SEPSIS DIAGNOSTICS MARKET – COUNTRY OUTLOOK
8.1. COUNTRY
ANALYSIS
8.1.1. UNITED
STATES
8.1.2. CANADA
9. COMPETITIVE
LANDSCAPE
9.1. ABBOTT
LABORATORIES
9.2. BECTON
DICKINSON AND COMPANY (CR BARD)
9.3. BIOMERIEUX
SA
9.4. BRUKER
CORPORATION
9.5. CYTOSORBENTS
9.6. DANAHER
CORPORATION
9.7. EKF
DIAGNOSTICS
9.8. F
HOFFMANN-LA ROCHE
9.9. IMMUNEXPRESS
INC
9.10. LUMINEX
CORPORATION
9.11. RESPONSE
BIOMEDICAL CORPORATION
9.12. T2
BIOSYSTEMS INC
9.13. THERMO
FISHER SCIENTIFIC INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5: LIST OF BUSINESS EXPANSIONS &
DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS & MERGERS
TABLE 7: LIST OF NEW PRODUCT LAUNCHES
TABLE 8: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET,
BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY
PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 12: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS
TABLE 13: GRAM-POSITIVE BACTERIA CAUSING SEPSIS
TABLE 14: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY
TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: NORTH AMERICA SEPSIS DIAGNOSTICS
MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 3: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2020 & 2028 (IN %)
FIGURE 8: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 11: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY PATHOGEN, 2020 & 2028 (IN %)
FIGURE 15: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS,
2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY TESTING TYPE, 2020 & 2028 (IN %)
FIGURE 19: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA SEPSIS
DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 22: UNITED STATES SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: CANADA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)